• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支持性肿瘤皮肤病学——其效用和未来发展方向的叙述性综述。

Supportive oncodermatology-a narrative review of its utility and the way forward.

机构信息

Department of Medicine, National University Health System, Singapore, Singapore.

Division of Dermatology, Department of Medicine, National University Health System, Singapore, Singapore.

出版信息

Support Care Cancer. 2021 Sep;29(9):4931-4937. doi: 10.1007/s00520-021-06124-w. Epub 2021 Mar 12.

DOI:10.1007/s00520-021-06124-w
PMID:33712911
Abstract

Supportive oncodermatology is an interdisciplinary field, emerging due to increasing dermatological morbidity in patients with cancer and the recognition of the need for greater collaborative and integrated care to improve patient outcomes. These two unique fields (Oncology and Dermatology) may be integrated in various ways, such as through specialised combined clinics, protocols for expedited access, multidisciplinary groups and meetings, and the development of best practices guidelines. This narrative review consolidates the small but growing literature surrounding supportive oncodermatology; discusses the potential benefit and disadvantages, and areas for future research; and suggests a framework for implementation.

摘要

支持性肿瘤皮肤科是一个跨学科领域,随着癌症患者皮肤科发病率的增加,以及认识到需要更大程度的协作和综合护理以改善患者结局,该领域应运而生。这两个独特的领域(肿瘤学和皮肤科)可以通过多种方式进行整合,例如通过专门的联合诊所、加速获得治疗的方案、多学科小组和会议,以及制定最佳实践指南。本文对支持性肿瘤皮肤科领域的少量但不断增长的文献进行了综述;讨论了潜在的益处和缺点,以及未来的研究领域;并提出了实施的框架。

相似文献

1
Supportive oncodermatology-a narrative review of its utility and the way forward.支持性肿瘤皮肤病学——其效用和未来发展方向的叙述性综述。
Support Care Cancer. 2021 Sep;29(9):4931-4937. doi: 10.1007/s00520-021-06124-w. Epub 2021 Mar 12.
2
The Role of Oncodermatology in the Care of Patients Receiving Cancer Therapy.肿瘤皮肤病学在接受癌症治疗患者护理中的作用。
Semin Oncol Nurs. 2017 Nov;33(4):393-401. doi: 10.1016/j.soncn.2017.08.001. Epub 2017 Sep 22.
3
Supportive oncodermatology practices in Europe and the USA.欧洲和美国的支持性肿瘤皮肤病学实践。
J Eur Acad Dermatol Venereol. 2024 May;38(5):e440-e443. doi: 10.1111/jdv.19679. Epub 2023 Dec 6.
4
How to become a Multinational Association of Supportive Care in Cancer-designated center of excellence in supportive care in cancer.如何成为一个癌症支持治疗多国协会指定的癌症支持治疗卓越中心。
Curr Opin Oncol. 2023 Jul 1;35(4):282-287. doi: 10.1097/CCO.0000000000000949. Epub 2023 Apr 27.
5
The Influence of Supportive Oncodermatology Interventions on Patient Quality of Life: A Cross-Sectional Survey.支持性肿瘤皮肤病学干预对患者生活质量的影响:一项横断面调查。
J Drugs Dermatol. 2020 May 1;19(5):477-482.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Supportive care in cancer unit at the National Cancer Institute of Milan: a new integrated model of medicine in oncology.米兰国家癌症研究所癌症病房的支持性护理:肿瘤医学的新型综合模式。
Curr Opin Oncol. 2012 Jul;24(4):391-6. doi: 10.1097/CCO.0b013e328352eabc.
8
The importance of evidence-based supportive care practice guidelines in childhood cancer-a plea for their development and implementation.循证支持性护理实践指南在儿童癌症中的重要性——呼吁制定和实施这些指南。
Support Care Cancer. 2017 Apr;25(4):1121-1125. doi: 10.1007/s00520-016-3501-y. Epub 2016 Dec 8.
9
Enhancing integrated psychosocial oncology through leveraging the oncology social worker's role in collaborative care.通过发挥肿瘤社会工作者在协作护理中的作用来加强综合心理社会肿瘤学。
Psychooncology. 2020 Dec;29(12):2084-2090. doi: 10.1002/pon.5582. Epub 2020 Nov 1.
10
The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus.癌症相关皮肤毒性管理中皮肤化妆品的作用:国际专家共识。
Support Care Cancer. 2023 Nov 4;31(12):672. doi: 10.1007/s00520-023-08116-4.

引用本文的文献

1
Multidisciplinary Dermatology: A Framework from the Association of Academic Cosmetic Dermatology.多学科皮肤病学:学术性美容皮肤病学协会的一个框架
J Clin Aesthet Dermatol. 2025 Jun;18(6):18-21.
2
International survey on training of dermatology residents in supportive oncodermatology: the RESCUE study.关于支持性肿瘤皮肤病学中皮肤科住院医师培训的国际调查:RESCUE研究。
Support Care Cancer. 2025 Apr 24;33(5):412. doi: 10.1007/s00520-025-09459-w.
3
Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective.

本文引用的文献

1
Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors.接受 CDK4/6 抑制剂治疗的晚期乳腺癌患者出现白癜风样病变。
Breast Cancer Res Treat. 2021 Jan;185(1):247-253. doi: 10.1007/s10549-020-05914-w. Epub 2020 Sep 10.
2
Evaluation of a Comprehensive Skin Toxicity Program for Patients Treated With Epidermal Growth Factor Receptor Inhibitors at a Cancer Treatment Center.评价癌症治疗中心接受表皮生长因子受体抑制剂治疗的患者的综合皮肤毒性方案。
JAMA Dermatol. 2020 Oct 1;156(10):1079-1085. doi: 10.1001/jamadermatol.2020.1795.
3
Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study.
癌症治疗中皮肤毒性的管理:澳大利亚/新西兰视角
Cancers (Basel). 2024 Jul 12;16(14):2526. doi: 10.3390/cancers16142526.
4
Diagnostic accuracy of general dermatologists and supportive oncodermatologists for biopsied cutaneous immune-related adverse events.一般皮肤科医生和支持性肿瘤皮肤科医生对活检皮肤免疫相关不良事件的诊断准确性。
Support Care Cancer. 2022 Oct;30(10):7827-7831. doi: 10.1007/s00520-022-07233-w. Epub 2022 Jul 9.
门诊皮肤科会诊对伴有急性皮肤不良反应的肿瘤患者影响抗癌治疗中断:一项回顾性研究。
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1340-1347. doi: 10.1111/jdv.16159. Epub 2020 Feb 5.
4
Dermatology consultation reduces interruption of oncologic management among hospitalized patients with immune-related adverse events: A retrospective cohort study.皮肤科会诊可减少免疫相关不良事件住院患者肿瘤治疗的中断:一项回顾性队列研究。
J Am Acad Dermatol. 2020 Apr;82(4):994-996. doi: 10.1016/j.jaad.2019.09.026. Epub 2019 Sep 24.
5
Evaluation of supportive and barrier-protective skin care products in the daily prevention and treatment of cutaneous toxicity during systemic chemotherapy.在全身化疗期间,评估支持性和屏障保护性皮肤护理产品在皮肤毒性日常预防和治疗中的作用。
Onco Targets Ther. 2018 Sep 17;11:5865-5872. doi: 10.2147/OTT.S155438. eCollection 2018.
6
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.免疫检查点抑制剂治疗患者免疫相关不良反应的管理:美国临床肿瘤学会临床实践指南。
J Clin Oncol. 2018 Jun 10;36(17):1714-1768. doi: 10.1200/JCO.2017.77.6385. Epub 2018 Feb 14.
7
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.免疫疗法毒性管理:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2017 Jul 1;28(suppl_4):iv119-iv142. doi: 10.1093/annonc/mdx225.
8
Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel.日常基础皮肤护理在肿瘤患者皮肤毒性的预防、治疗和支持性护理中的作用:来自一个多国家专家小组的建议。
Cancer Manag Res. 2013 Dec 9;5:401-8. doi: 10.2147/CMAR.S52256. eCollection 2013.
9
Skin rash could predict the response to EGFR tyrosine kinase inhibitor and the prognosis for patients with non-small cell lung cancer: a systematic review and meta-analysis.皮肤皮疹可预测非小细胞肺癌患者对表皮生长因子受体酪氨酸激酶抑制剂的反应和预后:系统评价和荟萃分析。
PLoS One. 2013;8(1):e55128. doi: 10.1371/journal.pone.0055128. Epub 2013 Jan 30.
10
Algorithm for dermocosmetic use in the management of cutaneous side-effects associated with targeted therapy in oncology.用于管理肿瘤靶向治疗相关皮肤不良反应的皮肤化妆品使用算法。
J Eur Acad Dermatol Venereol. 2013 Sep;27(9):1071-80. doi: 10.1111/jdv.12082. Epub 2013 Feb 1.